Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta an... Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline. Mehr anzeigen
Innoviva Specialty Therapeutics, Inc., (“IST”) a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced it has entered into an exclusive distribution and license agreement with Basilea...
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as...
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as...
Core royalty platform continued strong performance, receiving GSK royalties of $60.5 million with 6% year-over-year growth Innoviva Specialty Therapeutics’ (IST) marketed portfolio achieved U.S...
Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.09 | -0.480512546716 | 18.73 | 19.385 | 15 | 471593 | 18.84979087 | CS |
| 4 | 1.18 | 6.75830469645 | 17.46 | 19.385 | 15 | 623765 | 18.22731448 | CS |
| 12 | -1.61 | -7.95061728395 | 20.25 | 21.28 | 15 | 717320 | 18.65573973 | CS |
| 26 | 0.28 | 1.52505446623 | 18.36 | 21.28 | 15 | 576478 | 18.97124902 | CS |
| 52 | 2.79 | 17.6025236593 | 15.85 | 21.28 | 14.325 | 601316 | 17.29516993 | CS |
| 156 | 2.64 | 16.5 | 16 | 21.28 | 10.64 | 721617 | 15.34050144 | CS |
| 260 | 4.8 | 34.6820809249 | 13.84 | 21.28 | 7.58 | 711212 | 14.58191843 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
